Cardio Diagnostics Holdings, Inc. (CDIO)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenue | 7,475 | 940 | 6,580 | 7,870 |
| Sales and marketing | - | 41,820 | 52,059 | 57,779 |
| Research and development | - | 2,200 | 5,247 | 7,280 |
| General and administrative expenses | - | 1,542,042 | 1,353,439 | 1,220,477 |
| Amortization | - | 45,438 | 4,802 | 4,794 |
| Selling, general and administrative expenses | 1,686,174 | - | - | - |
| Total operating expenses | 1,686,174 | 1,631,500 | 1,415,547 | 1,290,330 |
| Loss from operations | -1,678,699 | -1,630,560 | -1,408,967 | -1,282,460 |
| Interest income | 190 | 187 | 280 | 282 |
| Interest expense | 4,690 | 4,691 | 3,879 | 5,817 |
| Total other income (expenses) | -4,500 | -4,504 | -3,599 | -5,535 |
| Loss before provision for income taxes | -1,683,199 | -1,635,064 | -1,412,566 | -1,287,995 |
| Provision for income taxes | - | - | - | - |
| Net loss | -1,683,199 | -1,635,064 | -1,412,566 | -1,287,995 |
| Net loss per common share, basic | -0.97 | -0.97 | -0.06 | -0.06 |
| Net loss per common share, diluted | -0.97 | -0.97 | -0.06 | -0.06 |
| Weighted average common shares outstanding, basic | 1,739,045 | 1,686,144 | 24,442,853 | 22,607,618 |
| Weighted average common shares outstanding, fully diluted | 1,739,045 | 1,686,144 | 24,442,853 | 22,607,618 |